APAF1 and Parkinson disease: applied an Apaf-1-dominant-negative variant that interferes with the formation of a functional Apaf-1-caspase 9 complex, to degenerating nigrostriatal neurons in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD (352).